Antonio Giordano is Professor of Pathology at Siena University, Italy. He currently serves also as Professor of Molecular Biology at the Temple University in Philadelphia, where he is also Director and founder of the Sbarro Institute for Cancer Research and Molecular Medicine.
Giordano was born in Naples, Italy, where he obtained his medical degree and PhD. He then moved to the US and worked at Cold Spring Harbor, under Nobel Laureate James Watson. Giordano research activity is mainly devoted to the study of the mechanisms responsible for cell cycle deregulation in cancer. Prof. Giordano discovered key regulators of the cell cycle and its pioneering studies contributed to the understanding of some of the central mechanisms of cancer development.
He discovered, in 1993, the tumor suppressor gene RBL2/p130, whose expression is altered in a wide variety of human cancers.
His current research activity is focused on the dissection of the mechanisms underlying cancer onset and progression, including breast, prostate, lung cancer and mesothelioma, and how to exploit these findings to identify new therapeutic strategies.
As a researcher, he has authored more than 700 articles, received over 30 awards for his contributions to cancer research, and is the holder of 18 patents. Giordano has trained numerous students, and written various academic, educational books and book chapters. He is a member of the editorial board of several international journals; has been an Invited Lecturer at hundreds of scientific meetings held within the US and abroad and has been awarded numerous national and international research grants.
Prof. Giordano has research team is particularly well-positioned to undertake the proposed research.